These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 1623227

  • 41. Cholinergic drug studies in dementia and depression.
    Newhouse PA.
    Adv Exp Med Biol; 1990; 282():65-76. PubMed ID: 2088086
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Effects of a single dose of the acetylcholinesterase inhibitor velnacrine on recognition memory and regional cerebral blood flow in Alzheimer's disease.
    Ebmeier KP, Hunter R, Curran SM, Dougal NJ, Murray CL, Wyper DJ, Patterson J, Hanson MT, Siegfried K, Goodwin GM.
    Psychopharmacology (Berl); 1992; 108(1-2):103-9. PubMed ID: 1410128
    [Abstract] [Full Text] [Related]

  • 45. Tacrine in Alzheimer's disease.
    Levy R.
    Lancet; 1989 Aug 05; 2(8658):329. PubMed ID: 2569126
    [No Abstract] [Full Text] [Related]

  • 46. Physostigmine and Alzheimer's disease.
    Gold M.
    Neurology; 1997 Aug 05; 49(2):642-3. PubMed ID: 9270628
    [No Abstract] [Full Text] [Related]

  • 47. Tacrine, and Alzheimer's treatments.
    Summers WK.
    J Alzheimers Dis; 2006 Aug 05; 9(3 Suppl):439-45. PubMed ID: 16914883
    [Abstract] [Full Text] [Related]

  • 48. [Pharma-clinics. Drug of the month. Tacrine (Cognex)].
    Scheen AJ.
    Rev Med Liege; 1996 May 05; 51(5):379-81. PubMed ID: 8992561
    [No Abstract] [Full Text] [Related]

  • 49. Physostigmine ameliorates the delusions of Alzheimer's disease.
    Cummings JL, Gorman DG, Shapira J.
    Biol Psychiatry; 1993 Apr 01; 33(7):536-41. PubMed ID: 8513039
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Invited review: Cholinesterase inhibitors for Alzheimer's disease therapy: from tacrine to future applications.
    Giacobini E.
    Neurochem Int; 1998 Apr 01; 32(5-6):413-9. PubMed ID: 9676739
    [Abstract] [Full Text] [Related]

  • 52. Cholinesterase inhibitors and opiate antagonists in patients with Alzheimer's disease.
    N Engl J Med; 1983 Sep 01; 309(9):555-6. PubMed ID: 6877328
    [No Abstract] [Full Text] [Related]

  • 53. Alzheimer's disease: a treatment in sight?
    Lovestone S, Howard R.
    J Neurol Neurosurg Psychiatry; 1995 Dec 01; 59(6):566-7. PubMed ID: 7500092
    [No Abstract] [Full Text] [Related]

  • 54. Development of memory-enhancing agents in the treatment of Alzheimer's disease.
    Abernethy DR.
    J Am Geriatr Soc; 1987 Oct 01; 35(10):957-8. PubMed ID: 2888798
    [No Abstract] [Full Text] [Related]

  • 55. Pharmacokinetic studies of cholinesterase inhibitors.
    Johansson M, Nordberg A.
    Acta Neurol Scand Suppl; 1993 Oct 01; 149():22-5. PubMed ID: 8128833
    [Abstract] [Full Text] [Related]

  • 56. Differential responsivity of verbal and visual recognition memory to physostigmine and ACTH.
    Rose RP, Moulthrop MA.
    Biol Psychiatry; 1986 May 01; 21(5-6):538-42. PubMed ID: 3008865
    [No Abstract] [Full Text] [Related]

  • 57. Cholinergic strategies in the treatment of Alzheimer's disease.
    Davidson M, Stern RG, Bierer LM, Horvath TB, Zemishlani Z, Markofsky R, Mohs RC.
    Acta Psychiatr Scand Suppl; 1991 May 01; 366():47-51. PubMed ID: 1897375
    [Abstract] [Full Text] [Related]

  • 58. Advances in the pharmacotherapy of Alzheimer's disease.
    Gauthier S.
    CMAJ; 2002 Mar 05; 166(5):616-23. PubMed ID: 11898943
    [No Abstract] [Full Text] [Related]

  • 59. Reduction of motoric agitation and restlessness by AF102B and tacrine in the macaque.
    Fitten LJ, Ortiz F, Siembieda DW, O'Neill J, Halgren E, Fisher A.
    J Neuropsychiatry Clin Neurosci; 1999 Mar 05; 11(1):79-85. PubMed ID: 9990560
    [Abstract] [Full Text] [Related]

  • 60. Frontal dysfunction blocks the therapeutic effect of THA on attention in Alzheimer's disease.
    Riekkinen P, Riekkinen M, Soininen H, Kuikka J, Laakso M, Riekkinen P.
    Neuroreport; 1997 May 27; 8(8):1845-9. PubMed ID: 9223063
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.